In the U.S., opioid-maker Purdue is bankrupt. Its global counterparts make millions.

Tactics used to persuade U.S. doctors that potent painkillers could be safely prescribed have been used abroad, an investigation shows.

View original article
Contributor: Madlen Davies , Hristio Boytchev, David Ovalle